Development of efficient method for synthesis of chemopreventors and study of its mechanism.
Project/Area Number |
25460030
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Chemical pharmacy
|
Research Institution | Tokushima Bunri University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
HORIKAWA MITSUYO 徳島文理大学, 大学院薬学研究科, 助教 (50148772)
KAKU HIROTO 徳島文理大学, 大学院薬学研究科, 準教授 (90299339)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
|
Keywords | 新光延試薬 / 不斉分子認識 / デラセミ化 / アブラムシ色素 / 不斉全合成 / 炭素-窒素形成反応 / デラセミ化法 / 不斉アザクライゼン転位 / 生体防御物質 / 新しい光延試薬 / ホスト分子 / アブラムシ / ポリケタイド系色素 / 昆虫病原菌 / 新光延反応 / 炭素ー窒素結合形成反応 / スルホンアミド / ホスト,ゲスト化学 / 全合成 |
Outline of Final Research Achievements |
We developed efficient method to convert molecular structure utilizing new Mitsunobu reaction and kinetic molecular recognition. For example, the use of host molecule with alkaline converted racemic 3-benzy-2-hexanone and to the S-isomer of 99% ee in 93% yield. Furthermore, new Mitsunobu reagents such as CMBP and CMMP prepared were mediated C-C and C-N forming reaction in excellent yield. Utilizing these new reaction, we synthesized polyketide pigments of aphid.
|
Report
(4 results)
Research Products
(23 results)
-
[Journal Article] Isolation and Total Syntheses of Cytotoxic Cryptolactones A1, A2, B1, and B2: α,β-Unsaturated δ-Lactones from a Cryptomyzus sp. Aphid.2014
Author(s)
M. Horikawa, M. Inai, Y. Oguri, E. Kuroda, M. Tanaka, S. Suzuki, T. Ito, S. Takahashi, H. Kaku, and T. Tsunoda
-
Journal Title
J. Nat. Prod.
Volume: 77
Issue: 11
Pages: 2459-2464
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-